vs
Side-by-side financial comparison of ENNIS, INC. (EBF) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
ENNIS, INC. is the larger business by last-quarter revenue ($100.2M vs $85.1M, roughly 1.2× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 10.8%, a 12.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.4%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $15.7M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 1.4%).
ENNIS, INC. (ticker EBF) is a leading North American provider of printed business products and related services. Its offerings include custom business forms, pressure-sensitive labels, marketing collateral, promotional items, and branded packaging, serving clients across retail, healthcare, financial services, and small business segments.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
EBF vs FDMT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $100.2M | $85.1M |
| Net Profit | $10.8M | $19.4M |
| Gross Margin | 31.9% | — |
| Operating Margin | 15.0% | 17.3% |
| Net Margin | 10.8% | 22.8% |
| Revenue YoY | 0.4% | 8508900.0% |
| Net Profit YoY | 6.1% | 139.1% |
| EPS (diluted) | $0.42 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $100.2M | $85.1M | ||
| Q3 25 | $98.7M | $90.0K | ||
| Q2 25 | $97.2M | $15.0K | ||
| Q1 25 | $92.7M | $14.0K | ||
| Q4 24 | $99.8M | $1.0K | ||
| Q3 24 | $99.0M | $3.0K | ||
| Q2 24 | $103.1M | $5.0K | ||
| Q1 24 | $97.4M | $28.0K |
| Q4 25 | $10.8M | $19.4M | ||
| Q3 25 | $13.2M | $-56.9M | ||
| Q2 25 | $9.8M | $-54.7M | ||
| Q1 25 | $9.0M | $-48.0M | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | $10.3M | $-43.8M | ||
| Q2 24 | $10.7M | $-35.0M | ||
| Q1 24 | $10.1M | $-32.4M |
| Q4 25 | 31.9% | — | ||
| Q3 25 | 30.5% | — | ||
| Q2 25 | 31.1% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 29.3% | — | ||
| Q3 24 | 30.1% | — | ||
| Q2 24 | 30.0% | — | ||
| Q1 24 | 28.4% | — |
| Q4 25 | 15.0% | 17.3% | ||
| Q3 25 | 12.5% | -67983.3% | ||
| Q2 25 | 13.7% | -396373.3% | ||
| Q1 25 | 13.0% | -383007.1% | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 13.3% | -1704400.0% | ||
| Q2 24 | 13.3% | -849120.0% | ||
| Q1 24 | 13.3% | -136200.0% |
| Q4 25 | 10.8% | 22.8% | ||
| Q3 25 | 13.3% | -63195.6% | ||
| Q2 25 | 10.1% | -364386.7% | ||
| Q1 25 | 9.7% | -342657.1% | ||
| Q4 24 | 10.2% | — | ||
| Q3 24 | 10.4% | -1461433.3% | ||
| Q2 24 | 10.4% | -699060.0% | ||
| Q1 24 | 10.4% | -115717.9% |
| Q4 25 | $0.42 | $0.43 | ||
| Q3 25 | $0.51 | $-1.01 | ||
| Q2 25 | $0.38 | $-0.98 | ||
| Q1 25 | $0.34 | $-0.86 | ||
| Q4 24 | $0.39 | — | ||
| Q3 24 | $0.40 | $-0.79 | ||
| Q2 24 | $0.41 | $-0.63 | ||
| Q1 24 | $0.39 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.3M | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $304.8M | $505.7M |
| Total Assets | $354.3M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.3M | $402.7M | ||
| Q3 25 | $31.9M | $305.1M | ||
| Q2 25 | $32.6M | $293.2M | ||
| Q1 25 | $72.5M | $321.4M | ||
| Q4 24 | $68.6M | $424.9M | ||
| Q3 24 | $122.6M | $501.9M | ||
| Q2 24 | $123.7M | $541.9M | ||
| Q1 24 | $110.9M | $525.9M |
| Q4 25 | $304.8M | $505.7M | ||
| Q3 25 | $305.4M | $369.0M | ||
| Q2 25 | $301.2M | $420.9M | ||
| Q1 25 | $302.0M | $469.7M | ||
| Q4 24 | $297.7M | $510.6M | ||
| Q3 24 | $358.4M | $552.9M | ||
| Q2 24 | $354.4M | $588.3M | ||
| Q1 24 | $349.8M | $600.6M |
| Q4 25 | $354.3M | $566.7M | ||
| Q3 25 | $361.8M | $424.0M | ||
| Q2 25 | $361.7M | $473.6M | ||
| Q1 25 | $348.9M | $515.7M | ||
| Q4 24 | $346.1M | $560.4M | ||
| Q3 24 | $406.8M | $604.0M | ||
| Q2 24 | $406.2M | $620.1M | ||
| Q1 24 | $399.2M | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.4M | $28.6M |
| Free Cash FlowOCF − Capex | $15.7M | $28.5M |
| FCF MarginFCF / Revenue | 15.7% | 33.5% |
| Capex IntensityCapex / Revenue | 0.7% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.52× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $42.5M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.4M | $28.6M | ||
| Q3 25 | $10.5M | $-46.5M | ||
| Q2 25 | $8.0M | $-43.4M | ||
| Q1 25 | $12.8M | $-47.8M | ||
| Q4 24 | $18.2M | $-134.6M | ||
| Q3 24 | $11.8M | $-29.4M | ||
| Q2 24 | $23.1M | $-30.2M | ||
| Q1 24 | $16.6M | $-29.1M |
| Q4 25 | $15.7M | $28.5M | ||
| Q3 25 | $9.0M | $-46.6M | ||
| Q2 25 | $6.6M | $-43.4M | ||
| Q1 25 | $11.1M | $-48.4M | ||
| Q4 24 | $17.5M | $-138.4M | ||
| Q3 24 | $10.7M | $-31.2M | ||
| Q2 24 | $20.6M | $-30.6M | ||
| Q1 24 | $15.0M | $-29.8M |
| Q4 25 | 15.7% | 33.5% | ||
| Q3 25 | 9.2% | -51765.6% | ||
| Q2 25 | 6.8% | -289620.0% | ||
| Q1 25 | 12.0% | -345635.7% | ||
| Q4 24 | 17.6% | -13837100.0% | ||
| Q3 24 | 10.8% | -1038966.7% | ||
| Q2 24 | 20.0% | -611840.0% | ||
| Q1 24 | 15.3% | -106421.4% |
| Q4 25 | 0.7% | 0.1% | ||
| Q3 25 | 1.4% | 101.1% | ||
| Q2 25 | 1.4% | 440.0% | ||
| Q1 25 | 1.8% | 4507.1% | ||
| Q4 24 | 0.6% | 378600.0% | ||
| Q3 24 | 1.1% | 59266.7% | ||
| Q2 24 | 2.4% | 6980.0% | ||
| Q1 24 | 1.7% | 2535.7% |
| Q4 25 | 1.52× | 1.47× | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 1.41× | — | ||
| Q4 24 | 1.78× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
